Cue Health is a healthcare technology company focused on developing and manufacturing consumer and professional medical diagnostic products that can be used in clinical or at-home settings.
Cue Health's mission is to create tools that empower physicians and consumers by increasing their access to actionable data.
Cue Health was founded in 2010 by Ayub Khattak and Clint Sever. The company is headquartered in San Diego, California.
Cue’s first product, the Cue Health Monitoring System, is a connected diagnostic platform. It enables a range of in-home and in-clinic diagnostics.
The Cue Health Monitoring System uses a highly portable reader system to test clinical samples in a disposable test cartridge and sends the results to a connected mobile application. The Cue Influenza test cartridge, which is undergoing clinical validation is designed to detect Influenza A and B.
Cue Health is backed by JJDC, Pritzker Group Venture Capital, Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, Babel Ventures, Sherpa Capital, Dentsu Ventures, BARDA and others. The company raised $100M in Series C round on June 10, 2020. This brings Cue's total funding to $168M to date. Cue has been awarded $13M contract on Mar 31, 2020.